Development of an integrated CRISPR interference system targeting ΔNp63 to treat lung and esophageal squamous cell carcinoma

被引：1
|
作者：
Yoshida, Masakazu [1 ]
Yokota, Etsuko [1 ]
Sakuma, Tetsushi [2 ]
Takigawa, Nagio [1 ]
Ushijima, Toshikazu [3 ]
Yamamoto, Takashi [2 ]
Naomoto, Yoshio [1 ]
Fukazawa, Takuya [1 ]
Yamatsuji, Tomoki [1 ]
机构：
[1] Kawasaki Med Sch, Okayama, Japan
[2] Hiroshima Univ, Hiroshima, Japan
[3] Natl Canc Ctr, Res Inst, Tokyo, Japan
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-3056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3056
引用
收藏
页数：2
相关论文
共 50 条
  • [41] ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma
    Bretz, Anne Catherine
    Gittler, Miriam P.
    Charles, Joel P.
    Gremke, Niklas
    Eckhardt, Ines
    Mernberger, Marco
    Mandic, Robert
    Thomale, Juergen
    Nist, Andrea
    Wanzel, Michael
    Stiewe, Thorsten
    NUCLEIC ACIDS RESEARCH, 2016, 44 (07) : 3204 - 3218
  • [42] Phospho-ΔNp63α-dependent microRNAs modulate chemoresistance of squamous cell carcinoma cells to cisplatin: At the crossroads of cell life and death
    Ratovitski, Edward A.
    FEBS LETTERS, 2013, 587 (16) : 2536 - 2541
  • [43] Development of a Specific Aptamer-Modified Nano-System to Treat Esophageal Squamous Cell Carcinoma
    Xie, Fei
    Qiu, Jinrong
    Sun, Congyong
    Feng, Lulu
    Jun, Yali
    Luo, Chao
    Guo, Xiamei
    Zhang, Bowei
    Zhou, Yu
    Wang, Yuting
    Zhang, Li
    Wang, Qilong
    ADVANCED SCIENCE, 2024, 11 (28)
  • [44] Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma
    Ravindran, Gokulan
    Devaraj, Halagowder
    CLINICAL ORAL INVESTIGATIONS, 2012, 16 (04) : 1275 - 1288
  • [45] Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma
    Gokulan Ravindran
    Halagowder Devaraj
    Clinical Oral Investigations, 2012, 16 : 1275 - 1288
  • [46] Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma
    Matsubara, Ryota
    Kawano, Shintaro
    Kiyosue, Takahiro
    Goto, Yuichi
    Hirano, Mitsuhiro
    Jinno, Teppei
    Toyoshima, Takeshi
    Kitamura, Ryoji
    Oobu, Kazunari
    Nakamura, Seiji
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (06) : 1391 - 1399
  • [47] p40 (ΔNp63), a Lung Squamous Cell Marker, Can Also Be Used to Label Breast Myoepithelial Cells
    Sarda, Rakesh
    Taylor, Jean
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (05) : 584 - 584
  • [48] Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma
    Hu, Lihua
    Liu, Jingpeng
    Li, Zhi
    Wang, Chunling
    Nawshad, Ali
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2016, 122 (04): : 460 - +
  • [49] ΔNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target
    Boldrup, Linda
    Coates, Philip J.
    Gu, Xiaolian
    Nylander, Karin
    JOURNAL OF PATHOLOGY, 2009, 218 (04): : 428 - 436
  • [50] Development a novel drug delivery formulation targeting to esophageal squamous cell carcinoma
    Feng, Yang
    Ge, Jingjing
    Zhang, Danying
    Bai, Xue
    Fang, Hongming
    Zhou, Yujuan
    Che, Wanlin
    Zhang, Wenxuan
    Zhao, Ruixia
    Qiu, Zuchun
    Zhao, Xuewei
    Xiao, Li
    He, Huimin
    Cheng, Sinan
    Duan, Wei
    Wang, Ruiju
    Chen, Wei
    Nie, Guochao
    Hou, Yingchun
    MATERIALS TODAY ADVANCES, 2023, 19
12345